Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

Cited by (432)

Items 401–432 of 432

1. Antiarrhythmic Drug Management of Atrial Fibrillation
   A. John Camm, Irina Savelieva · 2017 · Cardiovascular medicine
2. Testing novel pharmacological strategies for the management of atrial fibrillation in a large animal experimental model
   Viktor Juhász · 2017
3. Modeling Atrial Fibrillation using Human Embryonic Stem Cells
   Zachary Laksman · 2015 · TSpace (University of Toronto)
4. [Vaccination schedule for children].
   H Stickl · 1980 · PubMed
5. Pharmacologic Management of Supraventricular Tachycardias
   John Dimarco, James Michael Mangrum, John Ferguson · 2012 · Elsevier eBooks
6. Atrial Fibrillation and Thrombus in a Patient With a Fontan Circulation
   Seshadri Balaji, Ravi Mandapati, Gary D. Webb · 2018 · Elsevier eBooks
7. Typical Atrial Flutter
   Kevin Ming Wei Leong · 2019 · Springer eBooks
8. Common Atrial and Ventricular Arrhythmias
   Blair W. Foreman · 2018 · Contemporary cardiology
9. Antiarrhythmic agents and torsades de pointes
   Sojin Youn Wass, Mina K. Chung · 2022 · Elsevier eBooks
10. Strategies for prevention and management of QT interval prolongation and torsades de pointes
    Enoch Amarh, Brian R. Overholser · 2022 · Elsevier eBooks
11. Positive inotropic drugs and drugs used in dysrhythmias
    J.K. Aronson · 2003 · Side effects of drugs annual
12. Pharmacologic Management of Atrial Fibrillation and Flutter
    Deepak S. Saluja, Kathleen T. Hickey, James A. Reiffel · 2020 · Contemporary cardiology
13. Antiarrhythmics
    Jamie A. Decker, Timothy K. Knilans · 2014 · Springer eBooks
14. Proarrhythmia Syndromes
    Anne M. Gillis · 2012 · Elsevier eBooks
15. Antiarrhythmic drugs
    Rajesh Natarajan Subbiah, Terence John Campbell · 2011 · Elsevier eBooks
16. Dofetilide
    2006 · Elsevier eBooks
17. Dofetilide
    2015 · Elsevier eBooks
18. Antiarrhythmic Agents: a Review and Comment on Relevance in the Current Era—Part 2
    Seri Hanayneh, Mark Edward Panna, William M. Miles, Ramil Goel · 2021 · Current Treatment Options in Cardiovascular Medicine
19. Atrial Fibrillation
    Mihail Gabriel Chelu, Ali Oto, Tuan Dung Nguyen, Phan Dinh Phong, Tung Mai, THOMAS E. BUMP, Rajasekhar Nekkanti · 2016 · Wiley eBooks
20. ANTIDYSRHYTHMIC DRUGS
    2009 · Elsevier eBooks
21. Common Atrial and Ventricular Arrhythmias
    Blair W. Foreman · 2010 · Humana Press eBooks
22. PAPER: RECENT DEVELOPMENTS IN THE MANAGEMENT OF ATRIAL FIBRILLATION
    Stuart Hutcheon, P. Broadhurst · 2004 · The Journal of the Royal College of Physicians of Edinburgh
23. Class III Antiarrhythmic Drugs
    Eva Delpón, Ricardo Caballero, Juan Luis Tamargo · 2024 · Springer eBooks
24. Antiarrhythmic Drug Therapy for Acute Management of Atrial Fibrillation and Atrial Flutter
    Mohammadali Habibi, Muhammed A. Rahim, Suneet Mittal · 2025 · Cardiac Electrophysiology Clinics
25. Advances in Antiarrhythmic Drug Therapy
    Nikola Kocovic, Steven Liskov · 2025 · Cardiac Electrophysiology Clinics
26. New Results from Trials in Atrial Fibrillation
    Janet M. McComb · 2001 · Cardiac Electrophysiology Review
27. Ion channels of the human heart: A comprehensive four-chamber analysis
    Geoffrey E. Woodard · 2026 · Vascular Pharmacology
28. Safety of Dofetilide Initiation Following a Shortened Amiodarone Washout Period
    Isaac Burright, Freddy Del‐Carpio Munoz, Abhishek J. Deshmukh, Samuel J. Asirvatham, Suraj Kapa, Konstantinos C. Siontis, Peter A. Noseworthy, Ammar M. Killu, Alan M. Sugrue · 2026 · JACC. Clinical electrophysiology
29. 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation
    Emelia J. Benjamin, Gregory M. Marcus, Paul L. Hess, Daniel Addison, Joseph G. Akar, Nicholas Keisuke Brownell, Janice Y. Chyou, Catherine G. Derington, Rebecca L. Diekemper, David S. Frankel et al. · 2026 · Journal of the American College of Cardiology
30. 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
    Emelia J. Benjamin, Gregory M. Marcus, Paul L. Hess, Daniel Addison, Joseph G. Akar, Nicholas Keisuke Brownell, Janice Y. Chyou, Catherine G. Derington, Rebecca L. Diekemper, David S. Frankel et al. · 2026 · Circulation Population Health and Outcomes
31. Pharmacological Cardioversion of Atrial Fibrillation: Which Drugs Are Preferred, Class IC or Class III?
    N Baldi, Vitantonio Russo, Leonardo Di Gregorio, Vincenzo Morrone, L. Liconso, Giovanni Polimeni · 2006 · Springer eBooks
32. Pharmacological Prevention of Arrhythmic Recurrences
    Giacomo Chiarandà, M Cavarra, C.L. Romeo, M. Chiaranda, T. Regolo · 2006 · Springer eBooks